Vytorin for the Treatment of Hyperlipidemia
May 14, 2004 by admin · Leave a Comment
Vytorin is a combination therapy comprised of two drugs already separately approved for the treatment of hyperlipidemia. Zocor (simvistatin) and Zetia (ezetimibe) are combined in this oral medication currently awaiting an FDA decision on approval. Results released by Merck and Schering-Plough in March 2004 from Phase III clinical trials demonstrated that patients taking Zocor and [...]
FM-VP4 for the treatment of hyperlipidemia
April 2, 2004 by admin · Leave a Comment
On April 5, 2004 Forbes Medi-Tech Inc. announced preliminary results of its Phase II clinical trial of FM-VP4 for the treatment of hyperlipidemia. The company reported that statistical significance was achieved at the trial’s primary endpoint of lowering low density lipoprotein (LDL) cholesterol. An 11% reduction in LDL cholesterol, as compared to placebo, was reported [...]